HEADER TOXIN 19-APR-18 6D53 TITLE TRANS FORM OF HEMOLYSINII C-TERMINAL DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMOLYSIN II; COMPND 3 CHAIN: C; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, RESIDUES 319-412; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS CEREUS; SOURCE 3 ORGANISM_TAXID: 226900; SOURCE 4 STRAIN: ATCC 14579 / DSM 31 / JCM 2152 / NBRC 15305 / NCIMB 9373 / SOURCE 5 NRRL B-3711; SOURCE 6 ATCC: 14579; SOURCE 7 GENE: BC_3523; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 866768; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: BL21-GOLD(DE3)PLYSS AG; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PET28B KEYWDS PORE-FORMING TOXIN, PROLINE ISOMERIZATION, CONFORMATIONAL KEYWDS 2 HETEROGENEITY, TOXIN EXPDTA SOLUTION NMR NUMMDL 25 AUTHOR A.R.KAPLAN,A.T.ALEXANDRESCU,R.OLSON REVDAT 3 15-MAY-24 6D53 1 REMARK REVDAT 2 14-JUN-23 6D53 1 REMARK REVDAT 1 24-APR-19 6D53 0 JRNL AUTH A.R.KAPLAN,A.T.ALEXANDRESCU,R.OLSON JRNL TITL TRANS FORM OF HEMOLYSINII C-TERMINAL DOMAIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 2.3 REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6D53 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-APR-18. REMARK 100 THE DEPOSITION ID IS D_1000233336. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 310 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.0 MM [U-99% 13C; U-99% 15N] REMARK 210 HLYIIC, 20 MM SODIUM PHOSPHATE, REMARK 210 1 MM EDTA, 0.05 % W/V SODIUM REMARK 210 AZIDE, 1 MM AEBSF PROTEASE REMARK 210 INHIBITOR, 90% H2O/10% D2O; 1.0 REMARK 210 MM [U-99% 15N] HLYIIC, 20 MM REMARK 210 SODIUM PHOSPHATE, 1 MM EDTA, 1 REMARK 210 MM AEBSF PROTEASE INHIBITOR, REMARK 210 0.05 % W/V SODIUM AZIDE, 90% H2O/ REMARK 210 10% D2O; 1.0 MM [U-99% 15N] REMARK 210 HLYIIC, 20 MM SODIUM PHOSPHATE, REMARK 210 1.0 MM EDTA, 1.0 MM AEBSF REMARK 210 PROTEASE INHIBITOR, 0.05 % W/V REMARK 210 SODIUM AZIDE, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCACB; 3D HN(CO)CA; 3D HNCO; REMARK 210 3D HN(CA)CO; 2D 1H-15N HSQC; 3D REMARK 210 HNHA; 3D HNHB; 2D DQF-COSY; 2D REMARK 210 1H-1H NOESY; 2D 1H-13C HSQC; 2D REMARK 210 1H-1H TOCSY; 3D HCCH-TOCSY; 3D REMARK 210 CCH-TOCSY; 3D 1H-15N TOCSY; 3D REMARK 210 1H-13C NOESY ALIPHATIC; 3D 1H- REMARK 210 15N NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CCPNMR 2.4, FELIX, TALOS-N, REMARK 210 XPLOR NIH REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 25 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-25 REMARK 465 RES C SSSEQI REMARK 465 GLY C -3 REMARK 465 SER C -2 REMARK 465 HIS C -1 REMARK 465 MET C 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN C 2 -42.52 -152.99 REMARK 500 1 LEU C 6 -105.06 -92.18 REMARK 500 1 GLU C 8 -39.58 90.95 REMARK 500 1 MET C 10 -146.78 -77.00 REMARK 500 1 LYS C 24 -156.14 -76.01 REMARK 500 1 SER C 48 -169.85 -129.34 REMARK 500 1 VAL C 63 -61.20 -102.59 REMARK 500 1 ASN C 83 77.82 40.42 REMARK 500 2 GLU C 7 24.84 -74.57 REMARK 500 2 MET C 10 -147.52 -117.58 REMARK 500 2 LYS C 24 -157.71 -76.51 REMARK 500 2 SER C 48 -48.10 -179.08 REMARK 500 2 TYR C 49 -36.19 -171.45 REMARK 500 2 ASN C 83 82.36 36.66 REMARK 500 3 ASN C 2 -13.86 76.49 REMARK 500 3 MET C 10 -141.38 -110.69 REMARK 500 3 ASN C 11 -36.61 -39.80 REMARK 500 3 ASN C 42 28.74 81.59 REMARK 500 3 SER C 48 -79.46 -175.05 REMARK 500 3 TYR C 49 28.30 -168.48 REMARK 500 3 ASN C 83 78.09 38.34 REMARK 500 4 ASN C 2 -10.01 -157.47 REMARK 500 4 GLU C 8 -44.96 76.07 REMARK 500 4 MET C 10 -143.98 -87.65 REMARK 500 4 LYS C 24 -159.06 -70.64 REMARK 500 4 ASN C 34 33.78 -96.17 REMARK 500 4 ASN C 42 35.91 73.01 REMARK 500 4 SER C 48 -146.68 -178.26 REMARK 500 4 SER C 70 -147.83 -79.98 REMARK 500 4 ILE C 75 -70.08 -68.28 REMARK 500 4 ASN C 83 80.20 38.26 REMARK 500 4 LYS C 85 43.27 -81.98 REMARK 500 5 GLU C 8 -32.31 81.43 REMARK 500 5 MET C 10 -142.06 -82.29 REMARK 500 5 ASN C 11 -17.20 -49.95 REMARK 500 5 ASN C 42 26.33 81.08 REMARK 500 5 SER C 48 -87.37 -164.06 REMARK 500 5 TYR C 49 19.75 -169.24 REMARK 500 5 SER C 70 -150.73 -88.87 REMARK 500 5 ASN C 83 105.14 38.20 REMARK 500 5 LYS C 85 22.32 -149.85 REMARK 500 6 ALA C 5 -70.77 -91.60 REMARK 500 6 LEU C 6 -78.67 -92.32 REMARK 500 6 LYS C 24 -160.37 -78.96 REMARK 500 6 SER C 48 -53.83 177.36 REMARK 500 6 TYR C 49 -37.19 -166.40 REMARK 500 6 SER C 70 -118.80 -76.38 REMARK 500 6 ASN C 83 80.36 37.49 REMARK 500 6 LYS C 85 35.48 -66.83 REMARK 500 6 PRO C 87 -75.59 -80.50 REMARK 500 REMARK 500 THIS ENTRY HAS 199 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2N67 RELATED DB: PDB REMARK 900 2N67 IS A MUTANT FORM OF HLYIIC. REMARK 900 RELATED ID: 19462 RELATED DB: BMRB REMARK 900 TRANS FORM OF HEMOLYSINII C-TERMINAL DOMAIN DBREF 6D53 C 1 94 UNP Q81AN8 Q81AN8_BACCR 319 412 SEQADV 6D53 GLY C -3 UNP Q81AN8 EXPRESSION TAG SEQADV 6D53 SER C -2 UNP Q81AN8 EXPRESSION TAG SEQADV 6D53 HIS C -1 UNP Q81AN8 EXPRESSION TAG SEQADV 6D53 MET C 0 UNP Q81AN8 EXPRESSION TAG SEQRES 1 C 98 GLY SER HIS MET ASP ASN GLN LYS ALA LEU GLU GLU GLN SEQRES 2 C 98 MET ASN SER ILE ASN SER VAL ASN ASP LYS LEU ASN LYS SEQRES 3 C 98 GLY LYS GLY LYS LEU SER LEU SER MET ASN GLY ASN GLN SEQRES 4 C 98 LEU LYS ALA THR SER SER ASN ALA GLY TYR GLY ILE SER SEQRES 5 C 98 TYR GLU ASP LYS ASN TRP GLY ILE PHE VAL ASN GLY GLU SEQRES 6 C 98 LYS VAL TYR THR PHE ASN GLU LYS SER THR VAL GLY ASN SEQRES 7 C 98 ILE SER ASN ASP ILE ASN LYS LEU ASN ILE LYS GLY PRO SEQRES 8 C 98 TYR ILE GLU ILE LYS GLN ILE HELIX 1 AA1 MET C 10 ASN C 21 1 12 HELIX 2 AA2 THR C 71 LEU C 82 1 12 SHEET 1 AA1 2 LYS C 26 SER C 28 0 SHEET 2 AA1 2 THR C 39 SER C 41 -1 O THR C 39 N SER C 28 SHEET 1 AA2 3 GLU C 61 TYR C 64 0 SHEET 2 AA2 3 ILE C 56 VAL C 58 -1 N ILE C 56 O VAL C 63 SHEET 3 AA2 3 ILE C 89 ILE C 91 -1 O GLU C 90 N PHE C 57 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1